CA2439915A1 - Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes de recepteurs nk1 - Google Patents
Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes de recepteurs nk1 Download PDFInfo
- Publication number
- CA2439915A1 CA2439915A1 CA002439915A CA2439915A CA2439915A1 CA 2439915 A1 CA2439915 A1 CA 2439915A1 CA 002439915 A CA002439915 A CA 002439915A CA 2439915 A CA2439915 A CA 2439915A CA 2439915 A1 CA2439915 A1 CA 2439915A1
- Authority
- CA
- Canada
- Prior art keywords
- phenyl
- acid
- alkyl
- inhalable
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention concerne de nouvelles compositions médicamenteuses à base d'anticholinergiques et d'antagonistes de récepteurs NK1, leur procédé de production et leur utilisation dans le cadre du traitement de maladies des voies respiratoires.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10111058A DE10111058A1 (de) | 2001-03-08 | 2001-03-08 | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten |
DE10111058.8 | 2001-03-08 | ||
PCT/EP2002/001987 WO2002069944A2 (fr) | 2001-03-08 | 2002-02-26 | Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'antagonistes de recepteurs nk1 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2439915A1 true CA2439915A1 (fr) | 2002-09-12 |
Family
ID=7676673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002439915A Abandoned CA2439915A1 (fr) | 2001-03-08 | 2002-02-26 | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes de recepteurs nk1 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1370293A2 (fr) |
JP (1) | JP2004519484A (fr) |
AU (1) | AU2002251010A1 (fr) |
CA (1) | CA2439915A1 (fr) |
DE (1) | DE10111058A1 (fr) |
MX (1) | MXPA03008051A (fr) |
WO (1) | WO2002069944A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7244415B2 (en) | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
DE10214264A1 (de) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen eines Anhydrats |
DE10230750A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten |
WO2005004875A1 (fr) * | 2003-07-14 | 2005-01-20 | Sankyo Company, Limited | Composition medicinale a administration pulmonaire |
JP2006160639A (ja) * | 2004-12-06 | 2006-06-22 | Sankyo Co Ltd | ニューロキニン受容体拮抗剤と抗コリン剤の併用 |
ITRM20120331A1 (it) * | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
WO2015111627A1 (fr) * | 2014-01-21 | 2015-07-30 | 味の素株式会社 | Acide aminé de sucre et application associée |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3429338B2 (ja) * | 1992-07-27 | 2003-07-22 | 杏林製薬株式会社 | 新規なアリールグリシンアミド誘導体及びその製造法 |
US5545617A (en) * | 1993-11-12 | 1996-08-13 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
DE19608665A1 (de) * | 1996-03-06 | 1997-09-11 | Boehringer Ingelheim Kg | Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
US6124319A (en) * | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
EP1085875A1 (fr) * | 1998-06-11 | 2001-03-28 | MERCK SHARP & DOHME LTD. | Utilisation d'un antagoniste du recepteur nk-1 dans le traitement des troubles psychiatriques |
-
2001
- 2001-03-08 DE DE10111058A patent/DE10111058A1/de not_active Withdrawn
-
2002
- 2002-02-22 MX MXPA03008051A patent/MXPA03008051A/es not_active Application Discontinuation
- 2002-02-26 AU AU2002251010A patent/AU2002251010A1/en not_active Abandoned
- 2002-02-26 JP JP2002569121A patent/JP2004519484A/ja active Pending
- 2002-02-26 CA CA002439915A patent/CA2439915A1/fr not_active Abandoned
- 2002-02-26 EP EP02719915A patent/EP1370293A2/fr not_active Withdrawn
- 2002-02-26 WO PCT/EP2002/001987 patent/WO2002069944A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
MXPA03008051A (es) | 2003-12-04 |
DE10111058A1 (de) | 2002-09-12 |
AU2002251010A1 (en) | 2002-09-19 |
EP1370293A2 (fr) | 2003-12-17 |
WO2002069944A2 (fr) | 2002-09-12 |
JP2004519484A (ja) | 2004-07-02 |
WO2002069944A3 (fr) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6696042B2 (en) | Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists | |
US7776315B2 (en) | Pharmaceutical compositions based on anticholinergics and additional active ingredients | |
US7417051B2 (en) | Medicaments comprising betamimetics and a novel anticholinergic | |
US6608054B2 (en) | Pharmaceutical compositions based on anticholinergics and endothelin antagonists | |
CA2439763C (fr) | Compositions pharmaceutiques a base d'anticholinergiques et d'inhibiteurs de la pde-iv | |
US20040024007A1 (en) | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors | |
AU2003232201B2 (en) | Medicaments containing betamimetic drugs and a novel anticholinesterase drug | |
US20070208060A1 (en) | Compounds for treating inflammatory diseases | |
US20040266869A1 (en) | Novel medicament compositions based on anticholinesterase drugs and on ciclesonides | |
US20020193392A1 (en) | Pharmaceutical compositions based on tiotropium salts of salts of salmeterol | |
CA2436540C (fr) | Composition pharmaceutique a base d'anticholinergiques et de corticosteroides | |
US20030158196A1 (en) | Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors | |
IL155718A (en) | Pharmaceutical preparations based on tiotropium salts and salmetrol salts | |
US20100310477A1 (en) | Pharmaceutical compositions based on anticholingerics and additional active ingredients | |
US20040002502A1 (en) | Medicament combinations comprising heterocyclic compounds and a novel anticholinergic | |
US20040161386A1 (en) | Pharmaceutical compositions based on anticholinergic and dopamine agonists | |
US20040048886A1 (en) | Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists | |
WO2005013994A1 (fr) | Medicaments pour inhalation comportant un agent a activite anticholinergique et betamimetique | |
US20030203918A1 (en) | Pharmaceutical composition comprising an anticholinergic and a heterocyclic compound | |
US20020193394A1 (en) | Compounds for treating inflammatory diseases | |
CA2439915A1 (fr) | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes de recepteurs nk1 | |
AU2003216921A1 (en) | Medicaments containing steroids and a novel anticholinesterase drug | |
CA2441964C (fr) | Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'antagonistes de l'endotheline | |
NZ535166A (en) | New medicinal compositions on the basis of anticholinergic agents and EGFR kinase inhibitors | |
CA2430592C (fr) | Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'agonistes de la dopamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |